|
|
|
|
|
 |
|
|
| |
 |
CME ACTIVITY |
 |
|
| Optimizing Therapeutic Decision Making: PSA as a Biomarker for Benign Prostatic Hyperplasia Disease Progression |
| Proceedings from a Roundtable Symposium |
Activity Date: April 2003
Activity Info: Volume 3, (4D)
|
|
| |
|
|
|
|
Supported by an educational grant from |
| GlaxoSmithKline |
|
|
| |
|
|
|
|
|
|
|
|
|
|